🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, multicenter, open-label, single-arm clinical t...
Status
Unknown
Location
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University（Huai'an First People's Hospital）
Start Date
2023-09-15
Trial ID
NCT06445257
Treatments Being Tested
This is a prospective, single-center, single-arm, phase II study of Zanubru...
Status
Unknown
Location
Department of Medical Oncology, Sun Yat-sen University Cancer Center
Start Date
2021-01-31
Trial ID
NCT04736914
Treatments Being Tested
This study is a multi-center, open-label, single-arm, non-randomized phase ...
Status
Unknown
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2022-02-01
Trial ID
NCT05200312
This study is being conducted to evaluate the safety and efficacy of the co...
Status
Recruiting
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2024-04-25
Trial ID
NCT05681195
The proposed study is a prospective, single-center, single-arm and open-end...
Status
Unknown
Location
the First Affiliated Hospital of Soochow University
Start Date
2020-07-27
Trial ID
NCT05504603
Zanubrutinib is a novel BTK inhibitor with proven activity in patients with...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2021-09
Trial ID
NCT05117814
Treatments Being Tested
This is a single-center, open-label, prospective study enrolling high-risk ...
Status
Not Yet Recruiting
Location
Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2024-12-01
Trial ID
NCT06646666
Treatments Being Tested
Secondary central nervous system lymphoma (SCNSL) occurred in about 5% of p...
Status
Unknown
Location
Peking University Cancer Hospital & Institute
Start Date
2021-02-26
Trial ID
NCT05398224
Treatments Being Tested
This is a phase Ⅱ clinical study of Zanubrutinib(Z) in combination with met...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-01-01
Trial ID
NCT06646211
Treatments Being Tested
This is a phase II, open-label, multicentre study of Zanubrutinib-containin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-20
Trial ID
NCT06427213
Treatments Being Tested